L. Gianolio, K. Armstrong, Ewan Swann, Rhona Shepherd, Paul Henderson, David C Wilson, Richard K Russell
{"title":"OC5 正在接受静脉注射生物仿制药英夫利西单抗维持治疗的儿科炎症性肠病患者改用皮下注射英夫利西单抗的有效性和安全性:来自一个地区队列的实际数据","authors":"L. Gianolio, K. Armstrong, Ewan Swann, Rhona Shepherd, Paul Henderson, David C Wilson, Richard K Russell","doi":"10.1136/flgastro-2024-bspghan.5","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":6892,"journal":{"name":"Abstracts","volume":"13 7","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"OC5 Effectiveness and safety of switching to subcutaneous infliximab in paediatric inflammatory bowel disease patients on established intravenous biosimilar infliximab maintenance therapy: real world data from a regional cohort\",\"authors\":\"L. Gianolio, K. Armstrong, Ewan Swann, Rhona Shepherd, Paul Henderson, David C Wilson, Richard K Russell\",\"doi\":\"10.1136/flgastro-2024-bspghan.5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":6892,\"journal\":{\"name\":\"Abstracts\",\"volume\":\"13 7\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Abstracts\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/flgastro-2024-bspghan.5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/flgastro-2024-bspghan.5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
OC5 Effectiveness and safety of switching to subcutaneous infliximab in paediatric inflammatory bowel disease patients on established intravenous biosimilar infliximab maintenance therapy: real world data from a regional cohort